Frances Lasowski, PhD

CEO
20/20 OptimEyes Technologies
Stoney Creek, Ontario, Canada

Frances Lasowski has a background in biomaterials and drug delivery and has leveraged her experience with the C20/20 Innovation Hub to lead its spin out, 20/20 OptimEyes Technologies.

Disclosure information not submitted.

Presentation(s):

• Mucoadhesive Micelle Nanoparticles: A New Dosing Paradigm for Glaucoma Treatment

  Tuesday, July 15, 2025
  3:27 PM – 3:38 PM EDT